"Papageorgiou" Hospital
Thessaloniki, Greece
NCT Number: NCT04408807
The purpose is to assess the hypothesis that indirect ophthalmoscopy for retinopathy of prematurity eye examination (ROPEE) screening without the use of a lid speculum and scleral indentation (speculum-free, SpF) is less painful/stressful than funduscopy with speculum (Sp) and scleral indentation.
Looking for future studies?
Notify Me30 week–37 week
All sexes
Interventional
Not applicable
Thessaloniki, Greece
A prospective randomized cross-over study was conducted for the comparison of the two techniques of funduscopy for ROPEE screening, i.e. with (Sp) or without (SpF) the use of a speculum and indentor. A random number table was used to allocate participants into either a) receiving Sp funduscopy on their first and SpF on their second screening examination a week later, or b) receiving SpF first and Sp a week later.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Preterm neonates undergoing screening for ROP, i.e.
Exclusion criteria
Indirect ophthalmoscopy without the use of eyelid speculum and scleral indentation
Indirect ophthalmoscopy with the use of eyelid speculum and scleral indentation
Time frame: a) before the intervention [the effect of mydriasis (PIPP1)] b) at the end of the intervention [the effect of funduscopy (PIPP2)] c) 10-20 minutes after the intervention [the overall effect of the examination, i.e. mydriasis and funduscopy (PIPP3)]
Time frame: During the examination
Time frame: During the examination and during the 24 hours after the examination
Time frame: At the end of ROPEE screening
Time frame: During the examination
Aristotle University Of Thessaloniki
Other
Acronym: stressROP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05387941
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Lund, Skåne County, Sweden
View Trial DetailsNCT02820662
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Dijon, France
View Trial DetailsNCT06517836
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Portland, Oregon, United States
View Trial DetailsNCT05133999
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Paris, France
View Trial Details